We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.9B
AUM Growth
+$1.75B
(+7.2%)
Cap. Flow
+$434M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
23.48%
Holding
1,080
New
134
Increased
325
Reduced
445
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$189M |
| 2 |
Intel
INTC
|
+$180M |
| 3 |
Amphenol
APH
|
+$132M |
| 4 |
Intuit
INTU
|
+$106M |
| 5 |
Southwest Airlines
LUV
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$221M |
| 2 |
Constellation Energy
CEG
|
+$181M |
| 3 |
Uber
UBER
|
+$169M |
| 4 |
Mastercard
MA
|
+$140M |
| 5 |
Exelon
EXC
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.39% |
| 2 | Financials | 14.25% |
| 3 | Consumer Discretionary | 12.97% |
| 4 | Industrials | 12.61% |
| 5 | Healthcare | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
First Bancorp
FBP
$4.4B
| $24.8M | 0.1% |
1,169,168
+16,432
| +1% | +$334K |
|
202
Madison Square Garden
MSGE
$3.61B
| $24.4M | 0.09% |
573,616
-13,280
| -2% | -$519K |
|
203
Tandem Diabetes Care
TNDM
$1.15B
| $24.4M | 0.09% |
574,676
-669,464
| -54% | -$28.4M |
|
204
Iridium Communications
IRDM
$4.83B
| $24.3M | 0.09% |
798,675
-274,574
| -26% | -$7.48M |
|
205
Lennox International
LII
$19B
| $24.2M | 0.09% |
40,014
+2,060
| +5% | +$1.18M |
|
206
Bankunited
BKU
$3.39B
| $24.2M | 0.09% |
663,084
+39,797
| +6% | +$1.41M |
|
207
MYR Group
MYRG
$5.61B
| $24.1M | 0.09% |
+236,182
| New | +$26.8M |
|
208
Teradata
TDC
$2.8B
| $24M | 0.09% |
791,144
-50,941
| -6% | -$1.52M |
|
209
AXIS Capital
AXS
$8.63B
| $23.9M | 0.09% |
299,884
-18,108
| -6% | -$1.36M |
|
210
Organon & Co
OGN
$3.56B
| $23.8M | 0.09% |
1,242,135
+934,505
| +304% | +$19.4M |
|
211
CNO Financial Group
CNO
$4.98B
| $23.7M | 0.09% |
674,521
-33,753
| -5% | -$1.09M |
|
212
BOK Financial
BOKF
$8.64B
| $23.4M | 0.09% |
223,745
+48,942
| +28% | +$4.93M |
|
213
Netflix
NFLX
$297B
| $23.3M | 0.09% |
329,020
+100,010
| +44% | +$6.69M |
|
214
Mercury Insurance
MCY
$6.01B
| $23.2M | 0.09% |
368,305
-8,771
| -2% | -$521K |
|
215
Payoneer
PAYO
$2.41B
| $23.1M | 0.09% |
3,073,520
-269,298
| -8% | -$1.75M |
|
216
Fortrea Holdings
FTRE
$1.83B
| $22.7M | 0.09% |
1,135,619
+227,109
| +25% | +$5.34M |
|
217
Saia
SAIA
$11B
| $22.5M | 0.09% |
51,426
-11,584
| -18% | -$4.91M |
|
218
Travere Therapeutics
TVTX
$5.31B
| $22.2M | 0.09% |
1,590,377
-299,467
| -16% | -$3.12M |
|
219
Cavco Industries
CVCO
$4.45B
| $22.1M | 0.09% |
51,572
+3,615
| +8% | +$1.43M |
|
220
Texas Capital Bancshares
TCBI
$4.29B
| $22M | 0.08% |
308,222
+1,687
| +0.6% | +$110K |
|
|
TPC
221
Tutor Perini Cor
TPC
$4.41B
| $21.3M | 0.08% |
783,396
+441,858
| +129% | +$10.1M |
|
222
Broadcom
AVGO
$1.82T
| $21.1M | 0.08% |
122,506
-7,964
| -6% | -$1.28M |
|
|
CPRX
223
DELISTED
Catalyst Pharmaceutical
CPRX
| $21M | 0.08% |
1,057,390
-284,174
| -21% | -$5.27M |
|
|
RDFN
224
DELISTED
Redfin
RDFN
| $21M | 0.08% |
1,675,614
-349,260
| -17% | -$3.21M |
|
225
Northern Trust
NTRS
$22.2B
| $20.8M | 0.08% |
231,349
-4,298
| -2% | -$376K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2024 Portfolio in Review
As of Q3 2024, Jacobs Levy Equity Management held 1,080 positions worth $25.9B, up 7.2% from $24.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management's Q3 2024 filing shows 134 new, 325 increased, 445 reduced and 139 closed positions. Its largest new stake was Lam Research: 962,880 shares worth $78.6M. The largest sale was Fortinet, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2024 buy was Lam Research: 962,880 shares worth $78.6M.
- Jacobs Levy Equity Management added most to Edwards Lifesciences in Q3 2024, an estimated $189M increase.
- Jacobs Levy Equity Management's biggest Q3 2024 reduction was Fortinet, cutting an estimated $221M.
- Jacobs Levy Equity Management fully exited Smartsheet Inc. in Q3 2024, selling an estimated $81.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $25.9B portfolio in Q3 2024.
- Jacobs Levy Equity Management opened 134 new positions and closed 139 in Q3 2024.
- Jacobs Levy Equity Management's portfolio value rose 7.2% quarter-over-quarter to $25.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.